Atropine Auto-Injector

Open Pre-Solicitation Posted

Solicitation number
SPE2DP-27-R-ATRO
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Philadelphia, Pennsylvania 19111, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Logistics Agency Troop Support Medical is contemplating a firm-fixed-price, indefinite delivery/indefinite quantity contract for Atropine Injection automatic injectors (NSN 6505-31-017-0350) through a sources sought notice, with responses due November 30, 2026. No set-aside is used. The awardee must hold FDA approval to manufacture or sell the product before solicitation closing. The Government estimates 135,000 doses annually, with a guaranteed minimum of 90,000 and a maximum of 360,000 per contract term, totaling up to 1,800,000 doses over a one-year base term and four one-year options. It proposes a 30-day not-to-exceed quantity of 90,000 doses. Delivery is to DLA Distribution Susquehanna in New Cumberland, Pennsylvania, FOB Destination, with inspection and acceptance at destination.

The sources sought notice requests company identification, FDA registration or manufacturer commitment letters, commerciality certification, production capabilities, shipping requirements, and current and estimated unit pricing. Firms with products under development must describe their development stage and any completed laboratory or FDA testing. The attached MPID specifies a 2 mg atropine sulfate auto-injector delivering 0.66 to 0.80 mL within 0.5 seconds of activation, with a 36-month shelf life and at least 24 months remaining at delivery. It requires a certificate of sterility for each lot, individual sealed packaging with 480 units per exterior container, and operation between 39.2°F and 104°F at altitudes up to 33,000 feet with 99.5% reliability. The solicitation will post on DIBBS. Contracting Officer Jessica De La Hoz (jessica.delahoz@dla.mil, 445-737-3623) and Contract Specialist Alec Deichman (alec.deichman@dla.mil, 445-737-5743) are the points of contact.

Notice text

Please see attached for the sources sought notice/market research survey and MPID.

Files

File Type Posted
Atropine_MPID 2_2025-05-13_FINAL.pdf PDF
Atropine_Sources Sought Notice.docx DOCX document

Similar open opportunities

Opportunity Agency Set-aside Responses due
Epinephrine Injector NAICS 325412 Medical Supply Chain No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity